Magnetic resonance spectroscopy in Alzheimer’s disease
Jonathan Graff-Radford,1 Kejal Kantarci21Department of Neurology, 2Department of Radiology, Mayo Clinic, Rochester, MN, USAAbstract: Aging is the primary risk factor for dementia. With increasing life expectancy and aging populations worldwide, dementia is becoming one of the significant public heal...
Guardado en:
Autores principales: | Graff-Radford J, Kantarci K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/641a62ce47cf4e26bb4a41e7eddbcb55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015) -
Update on the use of memantine in Alzheimer’s disease
por: Robert J van Marum
Publicado: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012) -
Activation of mTOR: a culprit of Alzheimer’s disease?
por: Cai Z, et al.
Publicado: (2015) -
Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)